Michael Green, MD
Interventional Cardiology · Springdale, ARNPI 1437193612
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Abbott at 58.3% of the total. Reporting peaked in 2019 at $3,133 and has fallen 71.2% since, to $903 in 2025.
Across 313 payments — averaging $33.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Boston Scientific$1K
- Abiomed$884
- Amgen$754
- Inari Medical, Inc.$620
- Stryker$301
- plus $449 from 7 others
What the payments were for
- Food & beverage$10,27499%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 141 | $6,027 |
| Boston Scientific | 79 | $1,304 |
| Abiomed | 12 | $884 |
| Amgen | 53 | $754 |
| Inari Medical, Inc. | 9 | $620 |
| Stryker | 7 | $301 |
| Philips North America LLC | 5 | $107 |
| Penumbra, Inc. | 1 | $96 |
| Atricure, Inc. | 2 | $91 |
| Shockwave Medical, Inc | 1 | $84 |
| Cordis US CORP. | 1 | $30 |
| Medline Industries LP | 1 | $21 |
| Asahi Intecc USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,340 in reported general payments places this provider in the 70th percentile of 89 interventional cardiology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 342 | $262,024 |
| EliquisApixaban | 297 | $229,526 |
| XareltoRivaroxaban | 47 | $29,694 |
| Repatha SureclickEvolocumab | 25 | $21,583 |
| BrilintaTicagrelor | 31 | $18,286 |
| VerquvoVericiguat | 22 | $15,942 |
| MultaqDronedarone Hcl | 14 | $15,218 |
| Flecainide Acetate | 396 | $13,794 |
| SotalolSotalol Hcl | 352 | $6,272 |
| Ranolazine ErRanolazine | 63 | $5,236 |
| ClopidogrelClopidogrel Bisulfate | 680 | $4,795 |
| Propafenone Hcl | 52 | $3,196 |
| Digoxin | 191 | $3,194 |
| Clonidine | 15 | $2,298 |
| Isosorbide Dinitrate | 53 | $2,244 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Springdale
- Anthony KlappaSpringdale$22K
- Ahmad ElesberSpringdale$7K
- Gaurav DharLittle Rock$206K
- Ernesto Ruiz-RodriguezLittle Rock$153K
- Vasili LendelLittle Rock$86K
- Thomas WattsLittle Rock$68K
- Vijay RajaLittle Rock$46K
- Lena AwarJonesboro$43K
- Zubair AhmedFayetteville$36K
- Stephen BroughtonLittle Rock$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.